Isoderivative of deleted chromosome 20 in primary myelofibrosis (PMF) characterized by molecular cytogenetics and array CGH

Annals of Hematology

Volumn 88, Issue 11, 2009, Pages 1157-1159

  Douet Guilbert, N ^a,b,c   Andrieux, J ^d   Lai J L ^d   Morice, P ^e   Demory, J L ^f   Basinko, A ^a,b   Ugo, V ^b,c   Gueganic, N ^a   Le Bris, M J ^b   Morel, F ^a,b,c   Braekeleer, M ^a,b,c  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e Centre Hospitalier Pierre Le Damany   (France)

^f HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; JANUS KINASE 2; PROTEIN ATP9A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC2; TRANSCRIPTION FACTOR SALL4; UNCLASSIFIED DRUG; JAK2 PROTEIN, HUMAN;

AGED; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME 20; CHROMOSOME 20Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME G BAND; CHROMOSOME R BAND; COMPARATIVE GENOMIC HYBRIDIZATION; DICENTRIC CHROMOSOME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DISRUPTION; GENE LOCATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; ISOCHROMOSOME; KARYOTYPE 46,XX; LETTER; MYELOID METAPLASIA; PRIORITY JOURNAL; CHROMOSOME BREAKAGE; COMPARATIVE STUDY; GENE DOSAGE; GENETICS; METHODOLOGY;

AGED; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOCHROMOSOMES; JANUS KINASE 2; PRIMARY MYELOFIBROSIS;

EID: 70349433666     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0753-3     Document Type: Letter

References (8)

1. GFCH (2004) Recommandations pour la prise en charge cytogélnétique des syndromes myéloprolifératifs autres que la leucémie myélöde chronique (LMC) établies par le Groupe Français de Cytogénétique Hématologique (GFCH). Pathol Biol 52:241-244. doi: 10.1016/j.patbio.2004.04.003
2. Li T, Xue Y, Wu Y, Pan J (2004) Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-). Br J Haematol 125:337-342. doi: 10.1111/j.1365-2141.2004.04921.x
3. Saunders K, Czepulkowski B, Sivalingam R, Hayes JPLA, Aldouri M, Sekhar M, Cummins M, Ho A, Mufti GJ (2005) Isochromosome of a deleted 20q: A rare but recurrent chromosome abnormality in myelodysplastic syndromes. Cancer Genet Cytogenet 156:154-157. doi: 10.1016/ j.cancergencyto.2004.03.018
4. Lim TH, Lim AS, Tien SL (2006) A novel isoderivative chromosome 20 in a patient with chronic myelomonocytic leukemia. Cancer Genet Cytogenet 170:80-82. doi: 10.1016/j.cancergencyto.2006.04.005
5. Shetty S, Roland B (2008) Isoderivative chromosome 20 in bone marrow: three new cases. Cancer Genet Cytogenet 184:72-73. doi: 10.1016/ j.cancergencyto.2008.03.003
6. Douet-Guilbert N, Lai JL, Basinko A, Gueganic N, Andrieux J, Pollet B, Plantier I, Delattre C, Crepin O, Corm S, Le Bris MJ, Morel F, De Braekeleer M (2008) Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome. Br J Haematol 143:716-720. doi: 10.1111/j.1365-2141.2008.07436.x
7. Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A, Potter A (1997) Cytogenetic abnormalities and prognostic significance in idiopathic myelofibrosis: A study of 106 cases. Br J Haematol 98:96-102. doi: 10.1046/j.1365-2141.1997.1722990.x
8. Douet-Guilbert N, Basinko A, Morel F, Le Bris MJ, Ugo V, Morice P, Berthou C, De Braekeleer M (2008) Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: Characterization by molecular cytogenetics of commonly deleted and retained regions. Ann Hematol 87:537-544. doi: 10.1007/s00277-008-0462-3